World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
92
Citations
35255
World Ranking
2197
National Ranking
156

Medicine

D-Index
92
Citations
35653
World Ranking
11199
National Ranking
608

Karl Welte publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Karl Welte sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 517 publications — 95th percentile

95% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Karl Welte D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Karl Welte sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 92 D-Index — 89th percentile

89% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Research.com Recognitions

  • 2010 - German National Academy of Sciences Leopoldina - Deutsche Akademie der Naturforscher Leopoldina – Nationale Akademie der Wissenschaften Gynaecology and Paediatrics

Overview

Karl Welte is affiliated with the University of Tübingen in Germany. Their research spans medicine and biochemistry, genetics, and molecular biology, with a prominent focus on genetics, oncology, molecular biology, immunology, and physiology. Their work predominantly addresses blood disorders and treatments, neutropenia and cancer infections, erythrocyte function and pathophysiology, immunodeficiency and autoimmune disorders, acute myeloid leukemia research, ubiquitin and proteasome pathways, and hematological disorders and diagnostics.

Welte has contributed to various notable papers, including:

  • The European Guidelines on Diagnosis and Management of Neutropenia in Adults and Children: A Consensus Between the European Hematology Association and the EuNet-INNOCHRON COST Action (2023), published in HemaSphere
  • SRP54 mutations induce congenital neutropenia via dominant-negative effects on XBP1 splicing (2020), published in Blood
  • iPSC modeling of stage-specific leukemogenesis reveals BAALC as a key oncogene in severe congenital neutropenia (2021), published in Cell Stem Cell
  • NAMPT/SIRT2-mediated inhibition of the p53-p21 signaling pathway is indispensable for maintenance and hematopoietic differentiation of human iPS cells (2021), published in Stem Cell Research & Therapy
  • New insights into the pathomechanism of cyclic neutropenia (2020), published in Annals of the New York Academy of Sciences

Frequent co-authors collaborating with Welte include:

  • Julia Skokowa
  • Cornelia Zeidler
  • Maksim Klimiankou
  • Benjamin Dannenmann
  • Masoud Nasri

Welte publishes regularly in several scientific venues, with significant numbers of contributions in:

  • Blood
  • HemaSphere
  • Leukemia
  • Molecular Therapy
  • British Journal of Haematology

Their main fields of study encompass:

  • Medicine
  • Biochemistry, Genetics and Molecular Biology

The subfields of study Welte focuses on are:

  • Genetics
  • Oncology
  • Molecular Biology
  • Immunology
  • Physiology

The primary research topics addressed by Welte include:

  • Blood disorders and treatments
  • Neutropenia and Cancer Infections
  • Erythrocyte Function and Pathophysiology
  • Immunodeficiency and Autoimmune Disorders
  • Acute Myeloid Leukemia Research
  • Ubiquitin and proteasome pathways
  • Hematological disorders and diagnostics

In 2010, Karl Welte received recognition from the German National Academy of Sciences Leopoldina for contributions related to gynecology and paediatrics.

Best Publications

  • Use of double-stranded dna in exosomes: a novel biomarker in cancer detection

    David C. Lyden;Hector Peinado Selgas;Haiying Zhang;Basant Kumar Thakur

  • Recombinant human granulocyte colony-stimulating factor: effects on normal and leukemic myeloid cells

    Lawrence M. Souza;Thomas C. Boone;Janice Gabrilove;Por H. Lai

  • Effect of Granulocyte Colony-Stimulating Factor on Neutropenia and Associated Morbidity Due to Chemotherapy for Transitional-Cell Carcinoma of the Urothelium

    J.L. Gabrilove;J.L. Gabrilove;A. Jakubowski;A. Jakubowski;H. Scher;H. Scher;C. Sternberg;C. Sternberg

  • Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90. German-Austrian-Swiss ALL-BFM Study Group.

    Martin Schrappe;Alfred Reiter;Wolf-Dieter Ludwig;Jochen Harbott

  • Filgrastim (r-metHuG-CSF): The First 10 Years

    K Welte;J Gabrilove;MH Bronchud;E Platzer

  • Mutations in the gene encoding neutrophil elastase in congenital and cyclic neutropenia.

    David C. Dale;Richard E. Person;Audrey Anna Bolyard;Andrew G. Aprikyan

  • Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95

    Anja Möricke;Alfred Reiter;Martin Zimmermann;Helmut Gadner

  • Purification and biochemical characterization of human pluripotent hematopoietic colony-stimulating factor.

    Karl Welte;Erich Platzer;Li Lu;Janice L. Gabrilove

  • Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000

    A Möricke;M Zimmermann;A Reiter;G Henze

  • Effects of Recombinant Human Granulocyte Colony-Stimulating Factor on Neutropenia in Patients with Congenital Agranulocytosis

    Mary Ann Bonilla;Alfred P. Gillio;Mary Ruggeiro;Nancy A. Kernan

  • Recombinant human granulocyte colony-stimulating factor. Effects on hematopoiesis in normal and cyclophosphamide-treated primates.

    K. Welte;M. A. Bonilla;A. P. Gillio;T. C. Boone

  • HAX1 deficiency causes autosomal recessive severe congenital neutropenia (Kostmann disease)

    Christoph Klein;Magda Grudzien;Giridharan Appaswamy;Manuela Germeshausen

  • Late MRD response determines relapse risk overall and in subsets of childhood T-cell ALL: results of the AIEOP-BFM-ALL 2000 study

    Martin Schrappe;Maria Grazia Valsecchi;Claus R. Bartram;André Schrauder

  • Mutations in the gene for the granulocyte colony-stimulating-factor receptor in patients with acute myeloid leukemia preceded by severe congenital neutropenia

    Fan Dong;Russell K. Brynes;Nicola Tidow;Karl Welte

  • The incidence of leukemia and mortality from sepsis in patients with severe congenital neutropenia receiving long-term G-CSF therapy

    Philip S. Rosenberg;Blanche P. Alter;Audrey A. Bolyard;Mary Ann Bonilla

  • Severe chronic neutropenia: treatment and follow-up of patients in the Severe Chronic Neutropenia International Registry.

    David C. Dale;Tammy E. Cottle;Carol J. Fier;Audrey Anna Bolyard

  • Localized Ewing Tumor of Bone: Final Results of the Cooperative Ewing’s Sarcoma Study CESS 86

    M. Paulussen;S. Ahrens;J. Dunst;W. Winkelmann

  • Activation of human macrophages. Comparison of other cytokines with interferon-gamma.

    C F Nathan;T J Prendergast;M E Wiebe;E R Stanley

  • Diagnosis and Clinical Course of Autoimmune Neutropenia in Infancy: Analysis of 240 Cases

    Juergen Bux;Georg Behrens;Georg Behrens;Georg Behrens;Gudrun Jaeger;Gudrun Jaeger;Gudrun Jaeger;Karl Welte;Karl Welte;Karl Welte

  • Differential effects of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in children with severe congenital neutropenia.

    Karl Welte;Cornelia Zeidler;Alfred Reiter;Wolfgang Müller

Frequent Co-Authors

David C. Dale
David C. Dale University of Washington
Martin Stanulla
Martin Stanulla Hannover Medical School
Alfred Reiter
Alfred Reiter University of Giessen
Malcolm A.S. Moore
Malcolm A.S. Moore Memorial Sloan Kettering Cancer Center
Laurence A. Boxer
Laurence A. Boxer University of Michigan–Ann Arbor
Lothar Kanz
Lothar Kanz University of Tübingen
Martin Schrappe
Martin Schrappe Kiel University
Martin Zimmermann
Martin Zimmermann Hannover Medical School
Brigitte Schlegelberger
Brigitte Schlegelberger Hannover Medical School
Dirk Reinhardt
Dirk Reinhardt University of Duisburg-Essen

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Biology or Biochemistry in the USA opens doors to diverse career paths, including rapidly growing healthcare support roles. Graduates can branch into health information management, biotechnology, clinical research, and more. Among the most accessible and in-demand options is medical coding, which allows professionals to work in healthcare settings without direct patient care.

If you’re interested in this direction, understanding the medical coding certification options is a smart first step. Certifications such as CPC and CCS differ in cost, salary prospects, and focus, so it’s important to choose the best fit for your goals. Learning about certified medical coder salary reveals competitive annual earnings, especially with additional credentials or specialization.

The field is booming—explore whether is medical billing and coding in demand to get more insight into job stability and flexibility. For learners seeking affordable education, many universities offer the him degree online, combining advanced data management with healthcare knowledge. These programs help pave the way toward impactful, technology-driven healthcare careers.

Best Scientists Citing Karl Welte

Trending Scientists

Recently Published Articles